Export 2732 results:
Author Title Type [ Year(Asc)]
2022
E. G. Liu, Zhang, B., Martin, V., Anthonypillai, J., Kraft, M., Grishin, A., Grishina, G., Catanzaro, J. R., Chinthrajah, S., Sindher, T., Manohar, M., Quake, A. Zoe, Nadeau, K., A Burks, W., Kim, E. H., Kulis, M. D., Henning, A. K., Jones, S. M., Leung, D. Y. M., Sicherer, S. H., Wood, R. A., Yuan, Q., Shreffler, W., Sampson, H., Shabanova, V., and Eisenbarth, S. C., “Food-specific immunoglobulin A does not Correlate with Natural Tolerance to Peanut or Egg Allergens”, Sci Transl Med, vol. 14, no. 671, p. eabq0599, 2022.
A. Vena, Cao, D., and King, A., “Frontloading In The Real-World: Leveraging Smartphone Technology To Examine Rate Of Alcohol Consumption Effects On Subjective Responses In Heavy Drinkers”, in 45th Annual Speaker & Poster Abstracts of the Research Society on Alcoholism, Orlando, Florida, 2022.
S. C. Murphy, Vaughan, A. M., Kublin, J. G., Fishbauger, M., Seilie, A. M., Cruz, K. P., Mankowski, T., Firat, M., Magee, S., Betz, W., Kain, H., Camargo, N., Haile, M. T., Armstrong, J., Fritzen, E., Hertoghs, N., Kumar, S., D Sather, N., Pinder, L. F., Deye, G. A., Galbiati, S., Geber, C., Butts, J., Jackson, L. A., and Kappe, S. H. I., “A Genetically Engineered Plasmodium Falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection”, Sci Transl Med, vol. 14, no. 659, p. eabn9709, 2022.
T. P Korthuis, Cook, R. R., Lum, P. J., Waddell, E. Needham, Tookes, H., Vergara-Rodriguez, P., Kunkel, L. E., Lucas, G. M., Rodriguez, A. E., Bielavitz, S., Fanucchi, L. C., Hoffman, K. A., Bachrach, K., Payne, E. H., Collins, J. A., Matthews, A., Oden, N., Jacobs, P., Jelstrom, E., Sorensen, J. L., and McCarty, D., “HIV Clinic-based Extended-release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: a Non-blinded, Randomized Non-inferiority Trial”, Addiction, vol. 117, no. 7, pp. 1961-1971, 2022.
G. Meyers, Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A. C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M. L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P., and Levine, J. E., “Lessons Learned from Early Closure of a Clinical Trial for Steroid-refractory Acute GVHD”, Bone Marrow Transplant, vol. 57, no. 2, pp. 302-303, 2022.
G. J. Gorse, Grimes, S., Buck, H., Mulla, H., White, P., Hill, H., May, J., Frey, S. E., and Blackburn, P., “MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System, With Reduced Seasonal Influenza Vaccine Hemagglutinin Dose May Enhance Potency, Durability and Cross-Reactivity of Antibody Responses in the Elderly”, Vaccine, vol. 40, no. 10, pp. 1472-1482, 2022.
D. R. Stevens, Rohn, M. C. H., Hinkle, S. N., Williams, A. D., Kumar, R., Lipsky, L. M., Grobman, W., Sherman, S., Kanner, J., Chen, Z., and Mendola, P., “Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy”, PLoS One, vol. 17, no. 4, p. e0267122, 2022.
I. U. Scott, VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., and Blodi, B. A., “Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion”, Am J Ophthalmol, vol. 240, pp. 330-341, 2022.
Q. Bashir, Nishihori, T., Pasquini, M. C., Martens, M. J., Wu, J., Alsina, M., Anasetti, C., Brunstein, C., Dawson, P., Efebera, Y., Gasparetto, C., Geller, N., Giralt, S., Hall, A. C., Koreth, J., McCarthy, P., Scott, E., Stadtmauer, E. A., Vesole, D. H., and Hari, P., “A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial”, Transplant Cell Ther, vol. S2666-6367, no. 22, pp. 01467-1, 2022.
L. Lai, Rouphael, N., Xu, Y., Kabbani, S., Beck, A., Sherman, A., Anderson, E. J., Bellamy, A., Weiss, J., Cross, K., and Mulligan, M. J., “An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.”, Vaccine, vol. 40, no. 49, pp. 7065-7072, 2022.
N. S. Karnik, Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. - I., R McHugh, K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., and Wu, L. - T., “The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study”, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
K. E. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., “Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy”, Matern Child Health J, vol. 26, no. 7, pp. 1488-1495, 2022.
D. Coulibaly, Kone, A. K., Traore, K., Niangaly, A., Kouriba, B., Arama, C., Zeguime, A., Dolo, A., Lyke, K. E., Plowe, C. V., Abebe, Y., Potter, G. E., Kennedy, J. K., Galbiati, S. M., Nomicos, E., Deye, G. A., Richie, T. L., James, E. R., Kc, N., B Sim, K. Lee, Hoffman, S. L., Doumbo, O. K., Thera, M. A., and Laurens, M. B., “PfSPZ-CVac Malaria Vaccine Demonstrates Safety Among Malaria-experienced Adults: A Randomized, Controlled Phase 1 Trial”, EClinicalMedicine, vol. 52, p. 101579, 2022.
T. P. Lodise, J O'Donnell, N., Balevic, S., Liu, X., Gu, K., George, J., Raja, S., Guptill, J. T., Zaharoff, S., Schwager, N., Fowler, V. G., Wall, A., Wiegand, K., and Chambers, H. F., “Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.”, Antimicrob Agents Chemother, vol. 66, no. 12, p. e0093622, 2022.
G. J. Gorse, Grimes, S., Buck, H., Mulla, H., White, P., Hill, H., May, J., Frey, S. E., and Blackburn, P., “A Phase 1 Dose-Sparing, Randomized Clinical Trial of Seasonal Trivalent Inactivated Influenza Vaccine Combined With MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System”, Vaccine, vol. 40, no. 9, pp. 1271-1281, 2022.
K. Gu, Ruff, D., Key, C., Thompson, M., Jiang, S., Sandison, T., and Flanagan, S., “A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects”, Clin Transl Sci, vol. 15, no. 7, pp. 1592-1598, 2022.
R. G. Greenberg, Landersdorfer, C. B., Rivera-Chaparro, N., Harward, M., Conrad, T., Nakamura, A., Kirkpatrick, C. M., Gu, K., Ghazaryhan, V., Osborn, B., and Walter, E. B., “Population Pharmacokinetics of Moxifloxacin in Children”, Paediatr Drugs, vol. 24, no. 2, pp. 163-173, 2022.
C. Byrnes, Botello-Harbaum, M., Clemons, T., Bailey, L., Valdes, K. M., and Coleman-Cowger, V. H., “Process and Strategies for Patient Engagement and Outreach in the Sickle Cell Disease (SCD) Community to Promote Clinical Trial Participation”, J Natl Med Assoc, vol. 114, no. 2, pp. 211-217, 2022.
K. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., “Qualitative Results from NIDA Grant”, Maternal Child Health, vol. 26, no. 7, 2022.
S. B. Sirima, Ouedraogo, A., Tiono, A. B., Kaboré, J. M., Bougouma, E. C., Ouattara, M. S., Kargougou, D., Diarra, A., Henry, N., Ouédraogo, I. N., Billingsley, P. F., Manoj, A., Abebe, Y., Kc, N., Ruben, A., Richie, T. L., James, E. R., Joshi, S., Shrestha, B., Strauss, K., Lyke, K. E., Plowe, C. V., Potter, G. E., Cox, C., Jones, W., Sim, B. K. L., Hoffman, S. L., and Laurens, M. B., “A Randomized Controlled Trial Showing Safety and Efficacy of A Whole Sporozoite Vaccine Against Endemic Malaria”, Sci Transl Med, vol. 14, no. 674, p. eabj3776, 2022.
L. Luznik, Pasquini, M. C., Logan, B., Soiffer, R. J., Wu, J., Devine, S. M., Geller, N., Giralt, S., Heslop, H. E., Horowitz, M. M., Jones, R. J., Litzow, M. R., Mendizabal, A., Muffly, L., Nemecek, E. R., O'Donnell, L., O'Reilly, R. J., Palencia, R., Schetelig, J., Shune, L., Solomon, S. R., Vasu, S., Ho, V. T., and Perales, M. - A., “Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies”, J Clin Oncol, vol. 40, no. 4, pp. 356-368, 2022.
E. E. Coates, Edupuganti, S., Chen, G. L., Happe, M., Strom, L., Widge, A., Florez, M. Burgos, Cox, J. H., Gordon, I., Plummer, S., Ola, A., Yamshchikov, G., Andrews, C., Curate-Ingram, S., Morgan, P., Nagar, S., Collins, M. H., Bray, A., Nguyen, T., Stein, J., Case, C. L., Kaltovich, F., Wycuff, D., C Liang, J., Carlton, K., Vazquez, S., Mascola, J. R., and Ledgerwood, J. E., “Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.”, Lancet Infect Dis, vol. 22, no. 8, pp. 1210-1220, 2022.
B. C Creech, Jimenez-Truque, N., Kown, N., Sokolow, K., Brady, E. J., Yoder, S., Solovay, K., Rubin, K., Noviello, S., Hensel, E., Selamawi, S., Bakare, A., Makowski, M., and Lu, K., “Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults”, Vaccine, vol. 40, no. 47, pp. 6740-6746, 2022.
T. P. Lodise, J O'Donnell, N., Raja, S., Guptill, J. T., Zaharoff, S., Schwager, N., Fowler, V. G., Beresnev, T., Wall, A., Wiegand, K., Chrisos, E. Serti, Balevic, S., and Chambers, H. F., “Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.”, Antimicrob Agents Chemother, vol. 66, no. 12, p. e0093522, 2022.
J. E. Lang, Hornik, C. D., Martz, K., Jacangelo, J., Anand, R., Greenberg, R., Hornik, C., Zimmerman, K., P Smith, B., Benjamin, D. K., and Laughon, M., “Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.”, Contemp Clin Trials Commun, vol. 30, p. 101025, 2022.